Sleep trackers could be what’s keeping you up

A gadget on your wrist at night may be meant to track your sleep, but the device may actually be what’s keeping you up. A recent study from the Journal of Clinical Sleep Medicine has found that not only are many sleep trackers inaccurate, but the stress they create with false analytics may keep their wearers up.

Studies have shown half of U.S. adults are considering buying a fitness- and sleep-tracking wearable. The research team from Chicago's Rush University and Feinberg School of Medicine at Northwestern University wanted to understand the overall impact of the devices and the data they create. Chronicling the stories of patients, the study describes how patients almost blindly believe in wearables being accurate, though below-par sleeping analytics may be keeping them up at night.

In one case, involving "Mr. R" as he was named by the researchers, the authors explained that his attempt to achieve a full eight-hour sleep resulted in increased stress. Inaccurate readings given the next morning that reported low levels of deep sleep negatively impacted Mr. R's sleep patterns. Researchers discovered the problem when the data did not merit such trust from users.

"It's great that so many people want to improve their sleep. However, the claims of these devices really outweigh validation of what they have shown to be doing," wrote lead author Kelly Glazer Baron, PhD, MPH. "They don't do a good job of estimating sleep accurately."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup